The effect of the variant could be limited to a certain subgroup of thyroid cancer/HT patients based on ethnicity, age, sex, environmental factors, etc. Therefore, the small sample size, small effect size, and subgroup-specific effects could explain the lack of significant TCF19 findings in the current study. This evidence concerns the gene TCF19 and thyroid gland carcinoma.